Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Nat Biotechnol. 2010 Oct;28(10):1049–1052. doi: 10.1038/nbt1010-1049

Figure 1. Greater rate of increase of genome-scale, compared to selected gene-focused publications, addressing cancer epigenetics.

Figure 1

While published genome-scale studies represent only about 2% of cancer epigenetics, the rate of increase over the last 5 years of cancer epigenomic studies appears double that of conventional selected gene-based analyses. Numbers are approximate from PubMed citation analysis; scales are different for gene-based and genome-based plots; 2010 is extrapolated from 2/3 of 2009 plus 2010.